Innovative Financing for Healthcare Expansion
R-Bridge Healthcare Fund, an affiliate of CBC Group, has recently announced a significant financing effort aimed at supporting Human Investments Ltd. with up to US$50 million. This funding symbolizes a pivotal step towards expanding the market presence of Motiva® devices, designed to enhance women's health.
About the Financing Details
The financing will be non-dilutive, meaning it won't affect ownership stakes in Human Investments Ltd. It features a synthetic royalty component that links the funding availability to specific sales milestones. The financial support is especially tailored to ensure that Human Investments can grow sustainably, achieve objectives, and continue to innovate in the realm of healthcare solutions.
Impact on Motiva® Market Expansion
Human Investments Ltd. aims to utilize these funds to expand the reach of Motiva® devices in various regions, including Korea and China. As the exclusive distributor of Establishment Labs Holdings Inc.'s advanced femtech solutions, Human Investments Ltd. is on a trajectory of growth. With their proven success in the Korean market, they look forward to replicating that model in other Asian markets.
Leaders' Perspectives on the Partnership
Dr. Michael Keyoung, the Senior Managing Director & Head of Private Credit and Royalty at CBC Group, expressed excitement about the collaboration, stating that R-Bridge is enthusiastic about the commercial launch of Human Investments Ltd.'s innovative solutions. He acknowledged the company’s impressive performance and emphasized the commitment of R-Bridge to support high-quality healthcare initiatives.
Company Growth and Market Leadership
John Lim, the Founder and CEO of Human Investments Ltd., heralded the achievements reached in Korea, highlighting their brand Motiva® as a preferred choice among healthcare providers and patients. This funding is anticipated to empower further advancements, promoting Motiva® as an innovative option in medical aesthetics.
About R-Bridge Healthcare Fund
R-Bridge Healthcare Fund is a prominent player in the Asian healthcare investment landscape. With extensive assets under management and focusing on non-dilutive financing solutions, R-Bridge has established itself as a vital partner for healthcare companies striving for growth. The fund aims to deliver non-correlated returns to investors while aiding promising companies in the healthcare sector.
Investment Strategy and Vision
Founded with the mission to provide alternative financing to healthcare firms, R-Bridge utilizes revenue interests and royalties from healthcare products and services to fuel investments. This strategy not only supports the companies but also propels growth in innovative healthcare solutions that address pressing market needs.
About Human Investments Ltd.
Based in the United Arab Emirates, Human Investments Ltd. specializes in offering cutting-edge solutions in women's health through its distinct product lines. The Motiva® devices are characterized by their advanced technology and recognition for enhancing safety standards in breast health and aesthetics. With an increasing number of procedures and heightened consumer awareness, they are well-positioned to expand further, especially after recent approvals in significant markets.
Achievements and Market Traction
Over the last decade, nearly four million Motiva® devices have been utilized by healthcare professionals worldwide. The recent FDA approval in the U.S. marks a significant milestone, as it represents the first new breast implant PMA sanctioned by the FDA since 2013. This indicates a strong commitment to innovation and safety in the breast health sector.
Frequently Asked Questions
What is the significance of the financing for Human Investments Ltd.?
This financing enables Human Investments Ltd. to expand its operations and market presence for Motiva® devices in Asia.
How does the non-dilutive aspect of the financing benefit the company?
Non-dilutive financing protects the existing ownership structure of Human Investments Ltd. while still allowing for growth opportunities.
What markets will benefit from the expansion of Motiva® devices?
The primary focus is on the Korean and Chinese markets, where Human Investments Ltd. has established itself as a key player.
How does R-Bridge Healthcare Fund support healthcare companies?
R-Bridge provides funding through various innovative financing solutions aimed at unlocking growth potential for healthcare firms.
What innovative features do Motiva® devices offer?
Motiva® devices are renowned for their advanced safety technology and have gained recognition for their efficacy in breast aesthetics and reconstruction.
